Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
Related Posts
An Ultrasound Experiment Tackles a Giant Problem in Brain Medicine
There is a problem with the recently approved Alzheimer’s drug, Aduhelm. It can remove some of the amyloid that forms…
Nighttime Depression Is a Real Thing
There are lots of reasons your mood might tank at night. Here’s how to address the bedtime blues.
Trump Picks Stanford Physician Dr. Jay Bhattacharya to Head N.I.H.
As the director of the National Institutes of Health, Dr. Jay Bhattacharya would oversee the world’s premier medical research agency,…